Carbon footprint of inhalers in respiratory treatment: SABA CARBON International

A. Alzaabi (Abu Dhabi, United Arab Emirates), J. Bell (Cambridge, United Kingdom), F. Montero-Arias (San José, Costa Rica), D. Price (Aberdeen, United Kingdom), D. Jackson (London, United Kingdom), H. Wang (Taipei City, Taiwan), N. Budgen (Macclesfield, United Kingdom), H. Farouk (Dubai, United Arab Emirates), E. Maslova (Cambridge, United Kingdom)

Source: International Congress 2022 – Management of respiratory chronic conditions in primary care

Session: Management of respiratory chronic conditions in primary care
Session type: Thematic Poster
Number: 2026

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Alzaabi (Abu Dhabi, United Arab Emirates), J. Bell (Cambridge, United Kingdom), F. Montero-Arias (San José, Costa Rica), D. Price (Aberdeen, United Kingdom), D. Jackson (London, United Kingdom), H. Wang (Taipei City, Taiwan), N. Budgen (Macclesfield, United Kingdom), H. Farouk (Dubai, United Arab Emirates), E. Maslova (Cambridge, United Kingdom). Carbon footprint of inhalers in respiratory treatment: SABA CARBON International. 2026

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.